Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Anovulation 1

Interventions

Metformin 4Inositol 3drospirenone and ethinyl estradiol combination 2Progesterone 2Folic Acid 2Ethinyl Estradiol 2Cyproterone Acetate 2salicylsalicylic acid 1maltodextrin 1licogliflozin 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Time 1Thioctic Acid 1Sugars 1Spironolactone 1Sodium Salicylate 1Phlebotomy 1Lactalbumin 1Inulin 1Insulin 1Glycoprotein Hormones, alpha Subunit 1Flutamide 1Estrogens 1Estradiol 1Doxycycline 1Clomiphene 1Cardiovascular Physiological Phenomena 1Body Mass Index 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hyperandrogenism × salicylsalicylic acid × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡